New Study Uncovers Unprecedented Links Between Liver and Heart Health and the Importance of Doctors' Prioritizing Liver Health to Promote Heart Health
June 26, 2023
Perspectum and BluMaiden Biosciences Pte. Ltd. (“BluMaiden BioSciences”) Form Strategic Collaboration to Introduce Novel Insights into Clinical Trials
April 13, 2023
Perspectum Completes $19 Million Second Close of Series C Funding Led by Oppenheimer & Co. Inc. (“Oppenheimer”)
March 15, 2023
Perspectum Completes $36 Million First Close of Series C Funding Led by Oppenheimer Holdings
January 5, 2023
Leading Singaporean Diagnostic Center Increases MRI Capacity to Expand Patient Access to Perspectum’s LiverMultiScan
December 14, 2022
Perspectum and Nuance Collaborate to Scale Access to AI-Enabled Integrated Digital Care Platforms to Improve Patient Care for Metabolic Disease
November 28, 2022
FDA awards Perspectum major grant for the qualification of its noninvasive diagnostic biomarker to reduce liver biopsy in drug trials
September 27, 2022
LiverMultiScan shown to be a cost-effective alternative to liver biopsies for monitoring patients with autoimmune hepatitis
September 21, 2022
FDA Grants Clearance to Perspectum’s CoverScan – A New Platform-Based Tool to Assess Multiple Organs in One MRI Scan
May 22, 2022
